Skip to main content
SpringerLink
Log in

SPECT/CT Imaging in Hyperparathyroidism and Benign Thyroid Disorders

  • Chapter
  • First Online:
Clinical Applications of SPECT-CT

Abstract

SPECT/CT optimizes interpretation and diagnostic confidence, thereby enriching the nuclear physician's role in guiding clinical management of endocrine tumors. SPECT/CT has become an increasingly important tool in the preoperative evaluation of hyperparathyroidism. In order to optimize sensitivity and anatomic precision, the optimal protocol can combine dual tracer pinhole imaging with subtraction and SPECT/CT. SPECT/CT is also an essential tool before reoperative parathyroid surgery for persistent or recurrent hyperparathyroidism, whatever the setting. Its role in the work-up for benign thyroid disorders is currently much more limited.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Quarles LD. Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease. Exp Cell Res. 2012;318:1040–8. doi:10.1016/j.yexcr.2012.02.027.

    Article  CAS  PubMed  Google Scholar 

  2. Floege J, Kim J, Ireland E, Chazot C, Drueke T, de Francisco A, et al. Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant. 2011;26:1948–55. doi:10.1093/ndt/gfq219.

    Article  CAS  PubMed  Google Scholar 

  3. Sharma J, Raggi P, Kutner N, Bailey J, Zhang R, Huang Y, et al. Improved long-term survival of dialysis patients after near-total parathyroidectomy. J Am Coll Surg. 2012;214:400–7. doi:10.1016/j.jamcollsurg.2011.12.046; discussion 7–8.

    Article  PubMed  Google Scholar 

  4. Gagne ER, Urena P, Leite-Silva S, Zingraff J, Chevalier A, Sarfati E, et al. Short- and long-term efficacy of total parathyroidectomy with immediate autografting compared with subtotal parathyroidectomy in hemodialysis patients. J Am Soc Nephrol. 1992;3:1008–17.

    CAS  PubMed  Google Scholar 

  5. Triponez F, Clark OH, Vanrenthergem Y, Evenepoel P. Surgical treatment of persistent hyperparathyroidism after renal transplantation. Ann Surg. 2008;248:18–30. doi:10.1097/SLA.0b013e3181728a2d.

    Article  PubMed  Google Scholar 

  6. van Heerden JA, Grant CS. Surgical treatment of primary hyperparathyroidism: an institutional perspective. World J Surg. 1991;15:688–92.

    Article  PubMed  Google Scholar 

  7. Henry JF, Taieb D, Van Slycke S. Parathyroid localization and imaging. Endocr Surg (Springer Specialist Surgery Series). 2009:235–52. doi:10.1007/978-1-84628-881-4_17.

  8. Mihai R, Simon D, Hellman P. Imaging for primary hyperparathyroidism–an evidence-based analysis. Langenbecks Arch Surg. 2009;394:765–84. doi:10.1007/s00423-009-0534-4.

    Article  PubMed  Google Scholar 

  9. Mihai R, Barczynski M, Iacobone M, Sitges-Serra A. Surgical strategy for sporadic primary hyperparathyroidism an evidence-based approach to surgical strategy, patient selection, surgical access, and reoperations. Langenbecks Arch Surg. 2009;394:785–98. doi:10.1007/s00423-009-0529-1.

    Article  PubMed  Google Scholar 

  10. Taieb D, Hindie E, Grassetto G, Colletti PM, Rubello D. Parathyroid scintigraphy: when, how, and why? A concise systematic review. Clin Nucl Med. 2012;37:568–74. doi:10.1097/RLU.0b013e318251e408.

    Article  PubMed  Google Scholar 

  11. Kunstman JW, Kirsch JD, Mahajan A, Udelsman R. Clinical review: parathyroid localization and implications for clinical management. J Clin Endocrinol Metab. 2013;98:902–12. doi:10.1210/jc.2012-3168.

    Article  CAS  PubMed  Google Scholar 

  12. Ruda JM, Hollenbeak CS, Stack Jr BC. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg. 2005;132:359–72. doi:10.1016/j.otohns.2004.10.005.

    Article  PubMed  Google Scholar 

  13. Hindie E, Ugur O, Fuster D, O’Doherty M, Grassetto G, Urena P, et al. 2009 EANM parathyroid guidelines. Eur J Nucl Med Mol Imaging. 2009;36:1201–16. doi:10.1007/s00259-009-1131-z.

    Article  PubMed  Google Scholar 

  14. Bergenfelz AO, Hellman P, Harrison B, Sitges-Serra A, Dralle H. Positional statement of the European Society of Endocrine Surgeons (ESES) on modern techniques in pHPT surgery. Langenbecks Arch Surg. 2009;394:761–4. doi:10.1007/s00423-009-0533-5.

    Article  PubMed  Google Scholar 

  15. Bilezikian JP, Khan AA, Potts Jr JT. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab. 2009;94:335–9. doi:10.1210/jc.2008-1763.

    Article  CAS  PubMed  Google Scholar 

  16. Calzada-Nocaudie M, Chanson P, Conte-Devolx B, Delemer B, Estour B, Henry JF, et al. [Management of asymptomatic primary hyperparathyroidism: French Society of Endocrinology expert consensus]. Ann Endocrinol (Paris). 2006;67:7–12.

    Article  CAS  Google Scholar 

  17. Dotzenrath C, Cupisti K, Goretzki E, Mondry A, Vossough A, Grabensee B, et al. Operative treatment of renal autonomous hyperparathyroidism: cause of persistent or recurrent disease in 304 patients. Langenbecks Arch Surg. 2003;387:348–54. doi:10.1007/s00423-002-0322-x.

    CAS  PubMed  Google Scholar 

  18. Kovacevic B, Ignjatovic M, Zivaljevic V, Cuk V, Scepanovic M, Petrovic Z, et al. Parathyroidectomy for the attainment of NKF-K/DOQI and KDIGO recommended values for bone and mineral metabolism in dialysis patients with uncontrollable secondary hyperparathyroidism. Langenbecks Arch Surg. 2012. doi:10.1007/s00423-011-0901-9.

    PubMed  Google Scholar 

  19. Piga M, Bolasco P, Satta L, Altieri P, Loi G, Nicolosi A, et al. Double phase parathyroid technetium-99m-MIBI scintigraphy to identify functional autonomy in secondary hyperparathyroidism. J Nucl Med. 1996;37:565–9.

    CAS  PubMed  Google Scholar 

  20. Hindie E, Urena P, Jeanguillaume C, Melliere D, Berthelot JM, Menoyo-Calonge V, et al. Preoperative imaging of parathyroid glands with technetium-99m-labelled sestamibi and iodine-123 subtraction scanning in secondary hyperparathyroidism. Lancet. 1999;353:2200–4. doi:10.1016/S0140-6736(98)09089-8.

    Article  CAS  PubMed  Google Scholar 

  21. Torregrosa JV, Fernandez-Cruz L, Canalejo A, Vidal S, Astudillo E, Almaden Y, et al. (99m)Tc-sestamibi scintigraphy and cell cycle in parathyroid glands of secondary hyperparathyroidism. World J Surg. 2000;24:1386–90.

    Article  CAS  PubMed  Google Scholar 

  22. Taieb D, Urena-Torres P, Zanotti-Fregonara P, Rubello D, Ferretti A, Henter I, et al. Parathyroid scintigraphy in renal hyperparathyroidism: the added diagnostic value of SPECT and SPECT/CT. Clin Nucl Med. 2013. doi:10.1097/RLU.0b013e31829af5bf.

    PubMed  Google Scholar 

  23. Caldarella C, Treglia G, Pontecorvi A, Giordano A. Diagnostic performance of planar scintigraphy using (9)(9)mTc-MIBI in patients with secondary hyperparathyroidism: a meta-analysis. Ann Nucl Med. 2012;26:794–803. doi:10.1007/s12149-012-0643-y.

    Article  PubMed  Google Scholar 

  24. Vulpio C, Bossola M, De Gaetano A, Maresca G, Bruno I, Fadda G, et al. Usefulness of the combination of ultrasonography and 99mTc-sestamibi scintigraphy in the preoperative evaluation of uremic secondary hyperparathyroidism. Head Neck. 2010;32:1226–35. doi:10.1002/hed.21320.

    Article  PubMed  Google Scholar 

  25. Fuster D, Ybarra J, Ortin J, Torregrosa JV, Gilabert R, Setoain X, et al. Role of pre-operative imaging using 99mTc-MIBI and neck ultrasound in patients with secondary hyperparathyroidism who are candidates for subtotal parathyroidectomy. Eur J Nucl Med Mol Imaging. 2006;33:467–73. doi:10.1007/s00259-005-0021-2.

    Article  PubMed  Google Scholar 

  26. Gasparri G, Camandona M, Bertoldo U, Sargiotto A, Papotti M, Raggio E, et al. The usefulness of preoperative dual-phase 99mTc MIBI-scintigraphy and IO-PTH assay in the treatment of secondary and tertiary hyperparathyroidism. Ann Surg. 2009;250:868–71. doi:10.1097/SLA.0b013e3181b0c7f4.

    Article  PubMed  Google Scholar 

  27. Lumachi F, Ermani M, Basso S, Zucchetta P, Borsato N, Favia G. Localization of parathyroid tumours in the minimally invasive era: which technique should be chosen? Population-based analysis of 253 patients undergoing parathyroidectomy and factors affecting parathyroid gland detection. Endocr Relat Cancer. 2001;8:63–9.

    Article  CAS  PubMed  Google Scholar 

  28. Siperstein A, Berber E, Barbosa GF, Tsinberg M, Greene AB, Mitchell J, et al. Predicting the success of limited exploration for primary hyperparathyroidism using ultrasound, sestamibi, and intraoperative parathyroid hormone: analysis of 1158 cases. Ann Surg. 2008;248:420–8. doi:10.1097/SLA.0b013e3181859f71.

    PubMed  Google Scholar 

  29. Tublin ME, Pryma DA, Yim JH, Ogilvie JB, Mountz JM, Bencherif B, et al. Localization of parathyroid adenomas by sonography and technetium tc 99m sestamibi single-photon emission computed tomography before minimally invasive parathyroidectomy: are both studies really needed? J Ultrasound Med. 2009;28:183–90.

    PubMed  Google Scholar 

  30. Lumachi F, Tregnaghi A, Zucchetta P, Marzola MC, Cecchin D, Marchesi P, et al. Technetium-99m sestamibi scintigraphy and helical CT together in patients with primary hyperparathyroidism: a prospective clinical study. Br J Radiol. 2004;77:100–3.

    Article  CAS  PubMed  Google Scholar 

  31. Mihai R, Gleeson F, Buley ID, Roskell DE, Sadler GP. Negative imaging studies for primary hyperparathyroidism are unavoidable: correlation of sestamibi and high-resolution ultrasound scanning with histological analysis in 150 patients. World J Surg. 2006;30:697–704. doi:10.1007/s00268-005-0338-9.

    Article  PubMed  Google Scholar 

  32. Kebebew E, Hwang J, Reiff E, Duh QY, Clark OH. Predictors of single-gland vs multigland parathyroid disease in primary hyperparathyroidism: a simple and accurate scoring model. Arch Surg. 2006;141:777–82. doi:10.1001/archsurg.141.8.777; discussion 82.

    Article  PubMed  Google Scholar 

  33. Stephen AE, Roth SI, Fardo DW, Finkelstein DM, Randolph GW, Gaz RD, et al. Predictors of an accurate preoperative sestamibi scan for single-gland parathyroid adenomas. Arch Surg. 2007;142:381–6.

    Article  PubMed  Google Scholar 

  34. Erbil Y, Barbaros U, Yanik BT, Salmaslioglu A, Tunaci M, Adalet I, et al. Impact of gland morphology and concomitant thyroid nodules on preoperative localization of parathyroid adenomas. Laryngoscope. 2006;116:580–5. doi:10.1097/01.MLG.0000203411.53666.AD.

    Article  PubMed  Google Scholar 

  35. Lo CY, Lang BH, Chan WF, Kung AW, Lam KS. A prospective evaluation of preoperative localization by technetium-99m sestamibi scintigraphy and ultrasonography in primary hyperparathyroidism. Am J Surg. 2007;193:155–9. doi:10.1016/j.amjsurg.2006.04.020.

    Article  CAS  PubMed  Google Scholar 

  36. Siegel A, Alvarado M, Barth Jr RJ, Brady M, Lewis J. Parameters in the prediction of the sensitivity of parathyroid scanning. Clin Nucl Med. 2006;31:679–82. doi:10.1097/01.rlu.0000242212.23936.a7.

    Article  PubMed  Google Scholar 

  37. Berber E, Parikh RT, Ballem N, Garner CN, Milas M, Siperstein AE. Factors contributing to negative parathyroid localization: an analysis of 1000 patients. Surgery. 2008;144:74–9. doi:10.1016/j.surg.2008.03.019.

    Article  PubMed  Google Scholar 

  38. Swanson TW, Chan SK, Jones SJ, Bugis S, Irvine R, Belzberg A, et al. Determinants of Tc-99m sestamibi SPECT scan sensitivity in primary hyperparathyroidism. Am J Surg. 2010;199:614–20. doi:10.1016/j.amjsurg.2010.02.001.

    Article  PubMed  Google Scholar 

  39. Neumann DR, Esselstyn Jr CB, Go RT, Wong CO, Rice TW, Obuchowski NA. Comparison of double-phase 99mTc-sestamibi with 123I-99mTc-sestamibi subtraction SPECT in hyperparathyroidism. AJR Am J Roentgenol. 1997;169:1671–4.

    Article  CAS  PubMed  Google Scholar 

  40. Hindie E, Melliere D, Jeanguillaume C, Perlemuter L, Chehade F, Galle P. Parathyroid imaging using simultaneous double-window recording of technetium-99m-sestamibi and iodine-123. J Nucl Med. 1998;39:1100–5.

    CAS  PubMed  Google Scholar 

  41. Chen CC, Holder LE, Scovill WA, Tehan AM, Gann DS. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT. J Nucl Med. 1997;38:834–9.

    CAS  PubMed  Google Scholar 

  42. Caveny SA, Klingensmith 3rd WC, Martin WE, Sage-El A, McIntyre Jr RC, Raeburn C, et al. Parathyroid imaging: the importance of dual-radiopharmaceutical simultaneous acquisition with 99mTc-sestamibi and 123I. J Nucl Med Technol. 2012;40:104–10. doi:10.2967/jnmt.111.098400.

    Article  PubMed  Google Scholar 

  43. Rubello D, Massaro A, Cittadin S, Rampin L, Al-Nahhas A, Boni G, et al. Role of 99mTc-sestamibi SPECT in accurate selection of primary hyperparathyroid patients for minimally invasive radio-guided surgery. Eur J Nucl Med Mol Imaging. 2006;33:1091–4. doi:10.1007/s00259-006-0162-y.

    Article  CAS  PubMed  Google Scholar 

  44. Taieb D, Hassad R, Sebag F, Colavolpe C, Guedj E, Hindie E, et al. Tomoscintigraphy improves the determination of the embryologic origin of parathyroid adenomas, especially in apparently inferior glands: imaging features and surgical implications. J Nucl Med Technol. 2007;35:135–9. doi:10.2967/jnmt.107.039743.

    Article  PubMed  Google Scholar 

  45. Harari A, Mitmaker E, Grogan RH, Lee J, Shen W, Gosnell J, et al. Primary hyperparathyroidism patients with positive preoperative sestamibi scan and negative ultrasound are more likely to have posteriorly located upper gland adenomas (PLUGs). Ann Surg Oncol. 2011;18:1717–22. doi:10.1245/s10434-010-1493-2.

    Article  PubMed  Google Scholar 

  46. Henry JF, Sebag F, Cherenko M, Ippolito G, Taieb D, Vaillant J. Endoscopic parathyroidectomy: why and when? World J Surg. 2008;32:2509–15. doi:10.1007/s00268-008-9709-3.

    Article  PubMed  Google Scholar 

  47. Martinez-Rodriguez I, Banzo I, Quirce R, Jimenez-Bonilla J, Portilla-Quattrociocchi H, Medina-Quiroz P, et al. Early planar and early SPECT Tc-99m sestamibi imaging: can it replace the dual-phase technique for the localization of parathyroid adenomas by omitting the delayed phase? Clin Nucl Med. 2011;36:749–53. doi:10.1097/RLU.0b013e318217568a.

    Article  PubMed  Google Scholar 

  48. Lindqvist V, Jacobsson H, Chandanos E, Backdahl M, Kjellman M, Wallin G. Preoperative 99Tc(m)-sestamibi scintigraphy with SPECT localizes most pathologic parathyroid glands. Langenbecks Arch Surg. 2009;394:811–5. doi:10.1007/s00423-009-0536-2.

    Article  PubMed  Google Scholar 

  49. Lavely WC, Goetze S, Friedman KP, Leal JP, Zhang Z, Garret-Mayer E, et al. Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy. J Nucl Med. 2007;48:1084–9. doi:10.2967/jnumed.107.040428. jnumed.107.040428 [pii].

    Article  PubMed  Google Scholar 

  50. Perez-Monte JE, Brown ML, Shah AN, Ranger NT, Watson CG, Carty SE, et al. Parathyroid adenomas: accurate detection and localization with Tc-99m sestamibi SPECT. Radiology. 1996;201:85–91.

    CAS  PubMed  Google Scholar 

  51. Burke JF, Naraharisetty K, Schneider DF, Sippel RS, Chen H. Early-phase technetium-99m sestamibi scintigraphy can improve preoperative localization in primary hyperparathyroidism. Am J Surg. 2013;205:269–73. doi:10.1016/j.amjsurg.2013.01.001; discussion 73.

    Article  PubMed  Google Scholar 

  52. Patel CN, Salahudeen HM, Lansdown M, Scarsbrook AF. Clinical utility of ultrasound and 99mTc sestamibi SPECT/CT for preoperative localization of parathyroid adenoma in patients with primary hyperparathyroidism. Clin Radiol. 2010;65:278–87. doi:10.1016/j.crad.2009.12.005. S0009-9260(10)00024-3 [pii].

    Article  CAS  PubMed  Google Scholar 

  53. Pata G, Casella C, Besuzio S, Mittempergher F, Salerni B. Clinical appraisal of 99m technetium-sestamibi SPECT/CT compared to conventional SPECT in patients with primary hyperparathyroidism and concomitant nodular goiter. Thyroid. 2010;20:1121–7. doi:10.1089/thy.2010.0035.

    Article  CAS  PubMed  Google Scholar 

  54. Pata G, Casella C, Magri GC, Lucchini S, Panarotto MB, Crea N, et al. Financial and clinical implications of low-energy CT combined with 99m Technetium-sestamibi SPECT for primary hyperparathyroidism. Ann Surg Oncol. 2011;18:2555–63. doi:10.1245/s10434-011-1641-3.

    Article  PubMed  Google Scholar 

  55. Ciappuccini R, Morera J, Pascal P, Rame JP, Heutte N, Aide N, et al. Dual-phase 99mTc sestamibi scintigraphy with neck and thorax SPECT/CT in primary hyperparathyroidism: a single-institution experience. Clin Nucl Med. 2012;37:223–8. doi:10.1097/RLU.0b013e31823362e5. 00003072-201203000-00001 [pii].

    Article  PubMed  Google Scholar 

  56. Shafiei B, Hoseinzadeh S, Fotouhi F, Malek H, Azizi F, Jahed A, et al. Preoperative (9)(9)mTc-sestamibi scintigraphy in patients with primary hyperparathyroidism and concomitant nodular goiter: comparison of SPECT-CT, SPECT, and planar imaging. Nucl Med Commun. 2012;33:1070–6. doi:10.1097/MNM.0b013e32835710b6.

    Article  CAS  PubMed  Google Scholar 

  57. Schalin-Jantti C, Ryhanen E, Heiskanen I, Seppanen M, Arola J, Schildt J, et al. Planar scintigraphy with 123I/99mTc-sestamibi, 99mTc-sestamibi SPECT/CT, 11C-methionine PET/CT, or selective venous sampling before reoperation of primary hyperparathyroidism? J Nucl Med. 2013;54:739–47. doi:10.2967/jnumed.112.109561.

    Google Scholar 

  58. Zhen L, Li H, Liu X, Ge BH, Yan J, Yang J. The application of SPECT/CT for preoperative planning in patients with secondary hyperparathyroidism. Nucl Med Commun. 2013;34:439–44. doi:10.1097/MNM.0b013e32835f9447.

    Article  PubMed  Google Scholar 

  59. Vercellino L, Alaoui NI, Faugeron I, Berenger N, de Labriolle-Vaylet C, Hindie E, et al. Lingual thyroid imaging with (1)(2)(3)I SPECT/CT. Eur J Nucl Med Mol Imaging. 2011;38:1173. doi:10.1007/s00259-011-1747-7.

    Article  PubMed  Google Scholar 

  60. Macdonald W, Armstrong J. Benign struma ovarii in a patient with invasive papillary thyroid cancer: detection with I-131 SPECT-CT. Clin Nucl Med. 2007;32:380–2. doi:10.1097/01.rlu.0000259642.36291.0d.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, François Baclesse Cancer Centre, Caen, France

    Nicolas Aide MD, PhD & Stéphane Bardet MD

  2. Department of Nuclear Medicine, Haut-Lévêque Hospital, University of Bordeaux, Bordeaux, France

    Elif Hindié MD, PhD

  3. Department of Nuclear Medicine, La Timone University Hospital, European Center of Research in Medical Imaging (CERIMED), Aix-Marseille University, Marseilles, France

    David Taieb MD, PhD

Authors
  1. Nicolas Aide MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elif Hindié MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stéphane Bardet MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David Taieb MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David Taieb MD, PhD .

Editor information

Editors and Affiliations

  1. Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany

    Hojjat Ahmadzadehfar

  2. Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany

    Hans-Jürgen Biersack

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Aide, N., Hindié, E., Bardet, S., Taieb, D. (2014). SPECT/CT Imaging in Hyperparathyroidism and Benign Thyroid Disorders. In: Ahmadzadehfar, H., Biersack, HJ. (eds) Clinical Applications of SPECT-CT. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-35283-6_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-35283-6_3

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-35282-9

  • Online ISBN: 978-3-642-35283-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation